With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Semaglutide nausea is common: About 20 percent of Ozempic® ...
GLP-1 drugs like (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with ...
A new Cleveland Clinic study of nearly 8,000 patients found that people who stop popular GLP-1 weight-loss drugs often avoid ...
(Javier Zayas Photography/Moment/Getty Images) A new analysis suggests that people who stop taking Ozempic-like medications ...
PEORIA, Ill., Feb. 16, 2026 /PRNewswire/ -- What are the advantages of compounded semaglutide for weight loss, especially when administered in sublingual form? HelloNation has published an article ...
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to ...
Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...
The partnership focuses on enhancing patient reach for cutting-edge diabetes care and chronic weight management solutions.